Navigation Links
Transgenomic Reports Fourth Quarter Financial Results
Date:2/24/2010

6,004 $17,556 ======= ======= LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $1,013 $905 Other accrued expenses 2,517 2,810 Accrued compensation 573 520 Total current liabilities 4,103 4,235 Other long term liabilities 239 116 Total liabilities 4,342 4,351 STOCKHOLDERS' EQUITY 11,662 13,205 ------ ------ $16,004 $17,556 ======= =======

SOURCE Transgenomic, Inc.

Back to top

RELATED LINKS
http://www.transgenomic.com

'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
2. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
3. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
5. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
6. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
7. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
8. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2009 Financial Results
10. Par Pharmaceutical Companies Reports Adjusted EPS of $0.65 for Fourth Quarter 2009
11. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
(Date:9/4/2015)... ... September 05, 2015 , ... Paradise Valley Community ... for an exclusive, one-night exhibition of their work at Paradise Valley Community College. , ... September 18, from 6-9 pm. The artists will be on hand to meet the ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... According ... has been developed that changes color when subjected to an impact force that is ... could be implemented in helmets or other sporting equipment so that coaches or officials ...
(Date:9/4/2015)... ... September 04, 2015 , ... On the ... effectively doubled the size of its annual health tech innovation program. Now featuring ... health startups to compete for cash and prizes to advance their technologies toward ...
(Date:9/4/2015)... Denver, CO (PRWEB) , ... September 04, 2015 , ... ... highlights the ways in which a lack of funding for sidewalks, bike paths, and ... to the report, while the Denver region spends billions of dollars to expand public ...
(Date:9/4/2015)... ... 2015 , ... The Providence Fertility Center will host a Fertility Cocktail Hour" ... freezing. , Date and Time: October 8, 2015 at Waterman Grille restaurant and lounge, ... event will discuss the basics of female fertility and egg freezing, and offer women ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2
... According to the researchers, a vaginal gel, which is said ... against HIV, the virus that causes AIDS// expected to hit ... gels are being tested in a number of clinical trials ... years, the Associated Press reported. ,According to foodconsumer.org, ...
... TransforMED is sponsored by the American Academy of Family Physicians ... system. Dr. Joseph F. Mambu started his practice as a ... practice to a local hospital but in 2001, Mambu opened ... practice was selected to participate in a demonstration project, called ...
... report of a medical charity in the UK it ... the Patients and healthcare officials. //The Government though has ... through the current reforms. But the sad state is ... and the USA. This Picker Institute study report criticizes ...
... and report on the subject of using condoms top tackle ... said that the Vatican will soon publish a report based ... better to refrain from sex which is one the efficient ... previously the Archbishop of Milan, acknowledged the use of condoms ...
... a family history of alcoholism have an enhanced risk ... carry no such family history. Now, a recent study ... of alcoholism coupled with behavioral disinhibition run the greatest ... that they will become alcoholics. ,William R. ...
... a new study, patients with Parkinson’s show a decline ... A survey conducted amongst 210 nurse specialists// by the ... due to delays in medication or even lapses in ... admitted. ,Parkinson's disease patients experience tremors due ...
Cached Medicine News:Health News:Transformed Transforms Physician Centered Practice To Patient Centered One 2Health News:Is Alcoholism Genetic? 2
... refrigerated design for use as a specimen freezer ... 8000 sledge microtome, however, it can be used ... a large working area of 130 x 90mm ... adhesion between the specimen and the stage when ...
... is a refrigerated design for use as a ... with the 8000 sledge microtome, however, it can ... stage gives a large working area of 130 ... provide good adhesion between the specimen and the ...
... is necessary to cool a specimen below room ... to most microtomes and will permit specimen cooling ... conditions. The equipment consists of a cooling stage ... best suited for operation with a base sledge ...
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
Medicine Products: